AAP
ALT icon

Arax Advisory Partners’s Altimmune ALT Stock Holding History

Arax Advisory Partners’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.5K Buy
11,350
+11,011
+3,248% +$32.9K ﹤0.01% 3576
2026
Q1 		$1.04K Sell
339
-7,826
-96% -$33.2K ﹤0.01% 3290
2025
Q4 		$29.5K Buy
8,165
+4,076
+100% +$17.8K ﹤0.01% 1906
2025
Q3 		$15.4K Buy
4,089
+2,447
+149% +$9.45K ﹤0.01% 2391
2025
Q2 		$6.35K Buy
1,642
+1,028
+167% +$5.56K ﹤0.01% 2150
2025
Q1 		$3.07K Sell
614
-111
-15% -$703 ﹤0.01% 1950
2024
Q4 		$5.23K Buy
725
+592
+445% +$4.52K ﹤0.01% 1727
2024
Q3 		$817 Hold
133
– – ﹤0.01% 2316
2024
Q2 		$885 Buy
+133
New +$981 ﹤0.01% 2205

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arax Advisory Partners's ALT Position: Q2 2026 in Review

Arax Advisory Partners increased its Altimmune (ALT) stake by 3,248% in Q2 2026, buying an estimated $32.9K and bringing the position to 11,350 shares worth $34.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3576.

Arax Advisory Partners first reported a position in ALT in Q2 2024 and has held it in 9 quarters since. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Arax Advisory Partners held 11,350 shares of Altimmune worth $34.5K as of Q2 2026.
  • Arax Advisory Partners bought 11,011 Altimmune shares in Q2 2026, an estimated $32.9K.
  • Altimmune made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3576 holding.
  • Arax Advisory Partners first reported a position in Altimmune in Q2 2024 and has held it in 9 quarters since.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.